CompletedNCT06524830
VLS-01 buccal film compared with placebo for depression
About this title
Read the official source — NCT06524830Medication studyAges 18–65Multiple countries
Understand this study
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- Tucson and 47 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: December 30, 2024
- Recruitment status
- Completed
- Enrollment listed in the registry
- 142
- Sponsor
- atai Therapeutics, Inc.
- Sponsor type
- Biotech company
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States, Australia, Canada, ...
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06524830
- Official title
Show the full official title
A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled Trial to Assess the Efficacy, Safety, and Tolerability of Repeated Doses of VLS-01 Buccal Film in Participants With Treatment Resistant Depression
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Tucson, United States · Little Rock, United States · Rogers, United States
40 more locations
- Garden Grove, United States
- Glendale, United States
- La Jolla, United States
- Los Alamitos, United States
- Santa Monica, United States
- Denver, United States
- Hollywood, United States
- Miami, United States
- Tampa, United States
- Decatur, United States
- Savannah, United States
- Chicago, United States
- Baltimore, United States
- Rockville, United States
- Springfield, United States
- Watertown, United States
- Eden Prairie, United States
- Saint Charles, United States
- Eatontown, United States
- Toms River, United States
- New York, United States
- Columbus, United States
- North Canton, United States
- Moosic, United States
- Philadelphia, United States
- Austin, United States
- DeSoto, United States
- Plano, United States
- Draper, United States
- Bellevue, United States
- Camperdown, Australia
- Carlton, Australia
- Melbourne, Australia
- Northcote, Australia
- Parkville, Australia
- Surrey, Canada
- Kingston, Canada
- Doncaster, United Kingdom
- London, United Kingdom
- Motherwell, United Kingdom
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is atai Therapeutics, Inc.
Did this study involve medication?
Yes. The study involved medication, including VLS-01-203 BU and VLS-01-BU Placebo.
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
